HCTI: Healthcare Triangle Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Healthcare Triangle Inc (HCTI).
$5.59M Market Cap.
HCTI Market Cap. (MRY)
HCTI Shares Outstanding (MRY)
HCTI Assets (MRY)
Total Assets
$1.96M
Total Liabilities
$7.08M
Total Investments
$0
HCTI Income (MRY)
Revenue
$11.70M
Net Income
-$5.97M
Operating Expense
$7.64M
HCTI Cash Flow (MRY)
CF Operations
-$1.08M
CF Investing
$0
CF Financing
-$133.00K
HCTI Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $1,961,000 (-71.41%) | $6,858,000 (-48.29%) | $13,262,000 (-46.12%) | $24,613,000 (121.59%) |
Assets Current | $1,452,000 (-74.31%) | $5,653,000 (-29.53%) | $8,022,000 (-32.04%) | $11,804,000 (47.04%) |
Assets Non-Current | $509,000 (-57.76%) | $1,205,000 (-77.00%) | $5,240,000 (-59.09%) | $12,809,000 (315.89%) |
Goodwill & Intangible Assets | $0 (0%) | $857,000 (-79.02%) | $4,085,000 (-65.23%) | $11,747,000 (348.52%) |
Shareholders Equity | -$5,114,000 (-267.65%) | -$1,391,000 (-123.03%) | $6,040,000 (-62.57%) | $16,135,000 (272.77%) |
Property Plant & Equipment Net | $12,000 (-72.73%) | $44,000 (-45.00%) | $80,000 (-67.48%) | $246,000 (1458.34%) |
Cash & Equivalents | $20,000 (-98.38%) | $1,234,000 (-7.98%) | $1,341,000 (-24.24%) | $1,770,000 (26.19%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $1,607,000 (-58.78%) | $3,899,000 (-43.82%) | $6,940,000 (-33.83%) | $10,488,000 (53.31%) |
Trade & Non-Trade Payables | $2,539,000 (30.01%) | $1,953,000 (31.87%) | $1,481,000 (-20.93%) | $1,873,000 (-56.94%) |
Accumulated Retained Earnings (Deficit) | -$33,571,000 (-21.63%) | -$27,602,000 (-45.92%) | -$18,916,000 (-610.06%) | -$2,664,000 (-181.07%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $2,650,000 (-31.79%) | $3,885,000 (44.69%) | $2,685,000 (-22.26%) | $3,454,000 (357.85%) |
Debt Current | $2,650,000 (-30.04%) | $3,788,000 (41.08%) | $2,685,000 (-22.26%) | $3,454,000 (357.85%) |
Debt Non-Current | $0 (0%) | $97,000 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $7,075,000 (-14.23%) | $8,249,000 (14.22%) | $7,222,000 (-14.81%) | $8,478,000 (25.06%) |
Liabilities Current | $6,575,000 (-19.34%) | $8,152,000 (23.57%) | $6,597,000 (5.54%) | $6,251,000 (-7.79%) |
Liabilities Non-Current | $500,000 (415.46%) | $97,000 (-84.48%) | $625,000 (-71.94%) | $2,227,000 (0%) |
HCTI Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $11,696,000 (-64.77%) | $33,203,000 (-27.64%) | $45,886,000 (30.10%) | $35,270,000 (12.54%) |
Cost of Revenue | $8,806,000 (-66.68%) | $26,426,000 (-23.60%) | $34,591,000 (39.77%) | $24,748,000 (8.77%) |
Selling General & Administrative Expense | $6,153,000 (-40.82%) | $10,397,000 (-14.58%) | $12,172,000 (32.29%) | $9,201,000 (89.21%) |
Research & Development Expense | $429,000 (-46.31%) | $799,000 (-90.18%) | $8,138,000 (54.80%) | $5,257,000 (201.59%) |
Operating Expenses | $7,641,000 (-47.20%) | $14,472,000 (-47.60%) | $27,618,000 (73.92%) | $15,880,000 (114.33%) |
Interest Expense | $1,213,000 (25.31%) | $968,000 (356.60%) | $212,000 (-62.61%) | $567,000 (620.95%) |
Income Tax Expense | $12,000 (-65.71%) | $35,000 (-93.08%) | $506,000 (2008.33%) | $24,000 (-90.68%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$5,969,000 (31.28%) | -$8,686,000 (39.50%) | -$14,358,000 (-141.35%) | -$5,949,000 (-352.78%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$5,969,000 (31.28%) | -$8,686,000 (39.50%) | -$14,358,000 (-141.35%) | -$5,949,000 (-352.78%) |
Preferred Dividends Income Statement Impact | $7,435,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$5,969,000 (31.28%) | -$8,686,000 (39.50%) | -$14,358,000 (-141.35%) | -$5,949,000 (-352.78%) |
Weighted Average Shares | $5,278,293 (26.30%) | $4,179,140 (12.99%) | $3,698,555 (25.68%) | $2,942,786 (5.48%) |
Weighted Average Shares Diluted | $5,278,293 (26.30%) | $4,179,140 (12.99%) | $3,698,555 (25.68%) | $2,942,786 (5.48%) |
Earning Before Interest & Taxes (EBIT) | -$4,744,000 (38.25%) | -$7,683,000 (43.67%) | -$13,640,000 (-154.57%) | -$5,358,000 (-299.22%) |
Gross Profit | $2,890,000 (-57.36%) | $6,777,000 (-40.00%) | $11,295,000 (7.35%) | $10,522,000 (22.55%) |
Operating Income | -$4,751,000 (38.26%) | -$7,695,000 (52.86%) | -$16,323,000 (-204.65%) | -$5,358,000 (-555.34%) |
HCTI Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$12,000 (98.94%) | -$1,134,000 (85.14%) | -$7,629,000 (-1497.84%) |
Net Cash Flow from Financing | -$133,000 (-106.47%) | $2,056,000 (-66.06%) | $6,058,000 (-59.90%) | $15,108,000 (821.22%) |
Net Cash Flow from Operations | -$1,081,000 (49.74%) | -$2,151,000 (59.82%) | -$5,353,000 (24.73%) | -$7,112,000 (-868.05%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$1,214,000 (-1034.58%) | -$107,000 (75.06%) | -$429,000 (-216.89%) | $367,000 (-14.23%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$12,000 (70.00%) | -$40,000 (49.37%) | -$79,000 (0%) |
Issuance (Repayment) of Debt Securities | -$1,089,000 (-169.99%) | $1,556,000 (451.77%) | $282,000 (-68.24%) | $888,000 (-45.85%) |
Issuance (Purchase) of Equity Shares | $956,000 (91.20%) | $500,000 (-91.34%) | $5,776,000 (-59.38%) | $14,220,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $109,000 (-60.22%) | $274,000 (-28.08%) | $381,000 (-68.14%) | $1,196,000 (0%) |
Depreciation Amortization & Accretion | $889,000 (-43.23%) | $1,566,000 (-46.77%) | $2,942,000 (106.89%) | $1,422,000 (77.04%) |
HCTI Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 24.70% (21.08%) | 20.40% (-17.07%) | 24.60% (-17.45%) | 29.80% (8.76%) |
Profit Margin | -51.00% (-94.66%) | -26.20% (16.29%) | -31.30% (-85.21%) | -16.90% (-325.33%) |
EBITDA Margin | -33.00% (-79.35%) | -18.40% (21.03%) | -23.30% (-108.04%) | -11.20% (-200.90%) |
Return on Average Equity (ROAE) | 295.20% (287.67%) | -157.30% (-43.00%) | -110.00% (-89.33%) | -58.10% (-177.78%) |
Return on Average Assets (ROAA) | -121.70% (-96.93%) | -61.80% (10.95%) | -69.40% (-108.41%) | -33.30% (-237.04%) |
Return on Sales (ROS) | -40.60% (-75.76%) | -23.10% (22.22%) | -29.70% (-95.39%) | -15.20% (-276.74%) |
Return on Invested Capital (ROIC) | 258.50% (173.02%) | -354.00% (-44.84%) | -244.40% (-113.45%) | -114.50% (83.42%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.87 (33.86%) | -1.32 (-185.10%) | -0.46 (94.83%) | -8.96 |
Price to Sales Ratio (P/S) | 0.45 (28.61%) | 0.35 (138.62%) | 0.14 (-90.40%) | 1.51 |
Price to Book Ratio (P/B) | -1.09 (87.05%) | -8.44 (-781.28%) | 1.24 (-71.63%) | 4.37 |
Debt to Equity Ratio (D/E) | -1.38 (76.68%) | -5.93 (-595.82%) | 1.2 (127.81%) | 0.53 (-66.48%) |
Earnings Per Share (EPS) | -1.13 (45.67%) | -2.08 (46.39%) | -3.88 (-92.08%) | -2.02 (-340.48%) |
Sales Per Share (SPS) | 2.22 (-72.11%) | 7.95 (-35.96%) | 12.41 (3.51%) | 11.98 (6.69%) |
Free Cash Flow Per Share (FCFPS) | -0.2 (60.42%) | -0.52 (64.47%) | -1.46 (40.34%) | -2.44 (-829.28%) |
Book Value Per Share (BVPS) | -0.97 (-190.99%) | -0.33 (-120.39%) | 1.63 (-70.22%) | 5.48 (253.51%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.37 (-74.09%) | 1.44 (-42.12%) | 2.48 (-43.25%) | 4.37 (43.72%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (50.00%) | -2 (0%) | 0 (0%) | -14 |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.72 (30.41%) | -2.48 (-354.31%) | -0.55 (97.04%) | -18.38 |
Asset Turnover | 2.38 (1.02%) | 2.36 (6.50%) | 2.22 (12.25%) | 1.98 (-39.01%) |
Current Ratio | 0.22 (-68.11%) | 0.69 (-43.01%) | 1.22 (-35.59%) | 1.89 (59.46%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$1,081,000 (50.02%) | -$2,163,000 (59.89%) | -$5,393,000 (25.00%) | -$7,191,000 (-878.80%) |
Enterprise Value (EV) | $6,643,713 (-56.14%) | $15,145,935 (159.72%) | $5,831,671 (-91.94%) | $72,351,910 |
Earnings Before Tax (EBT) | -$5,957,000 (31.14%) | -$8,651,000 (37.55%) | -$13,852,000 (-133.79%) | -$5,925,000 (-326.94%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$3,855,000 (36.98%) | -$6,117,000 (42.82%) | -$10,698,000 (-171.80%) | -$3,936,000 (-212.69%) |
Invested Capital | -$1,984,000 (-496.80%) | $500,000 (-87.26%) | $3,924,000 (-52.72%) | $8,299,000 (682.19%) |
Working Capital | -$5,123,000 (-105.00%) | -$2,499,000 (-275.37%) | $1,425,000 (-74.34%) | $5,553,000 (344.77%) |
Tangible Asset Value | $1,961,000 (-67.32%) | $6,001,000 (-34.61%) | $9,177,000 (-28.67%) | $12,866,000 (51.57%) |
Market Capitalization | $5,589,713 (-52.40%) | $11,741,935 (56.94%) | $7,481,671 (-89.38%) | $70,479,137 |
Average Equity | -$2,022,250 (-136.62%) | $5,522,500 (-57.70%) | $13,055,500 (27.60%) | $10,231,685 (224.65%) |
Average Assets | $4,905,000 (-65.12%) | $14,063,000 (-32.05%) | $20,695,500 (15.87%) | $17,860,282 (84.51%) |
Invested Capital Average | -$1,835,250 (-184.55%) | $2,170,500 (-61.11%) | $5,580,750 (19.25%) | $4,679,997 (1301.51%) |
Shares | 5,666,781 (32.48%) | 4,277,572 (2.74%) | 4,163,423 (6.92%) | 3,893,875 (0.00%) |